REGENERON PHARMACEUTICALS, INC. Convertible Notes Payable, Noncurrent
REGENERON PHARMACEUTICALS, INC. (REGN) had Convertible Notes Payable, Noncurrent of $0 as of 2015-12-31, per its 10-K filed 2016-02-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2016-02-11
- 2015-12-31: Convertible Notes Payable, Noncurrent $0.00.
- 2015-09-30: Convertible Notes Payable, Noncurrent $30.72M.
- 2015-06-30: Convertible Notes Payable, Noncurrent $30.36M.
- 2015-03-31: Convertible Notes Payable, Noncurrent $144.08M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-11 |
| 2015-09-30 | $30.72M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $30.36M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $144.08M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $146.77M 10-K · filed 2016-02-11 |
| 2014-09-30 | $287.95M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $282.26M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $326.67M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $320.31M 10-K · filed 2015-02-12 |
| 2013-09-30 | $314.16M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $308.12M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $302.27M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $296.52M 10-K · filed 2014-02-13 |
| 2012-09-30 | $290.96M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $285.49M 10-Q · filed 2012-07-25 |
| 2012-03-31 | $280.21M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $275.02M 10-K · filed 2013-02-15 |
| 2010-12-31 | $0.00 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |